Належна практика реваскуляризації міокарда в пацієнтів з хронічними формами ішемічної хвороби серця: Критерії Американської колегії кардіологів / Американської асоціації торакальних хірургів / Американської асоціації серця / Американської асоціації спеціалістів з ехокардіографії / Американської асоціації спеціалістів з ядерної кардіології / Товариства спеціалістів із серцево-судинної ангіографії та втручань / Товариства спеціалістів із серцево-судинної комп’ютерної томографії / Товариства торакальних хірургів 2017 року
Робоча група з реваскуляризації вінцевих артерій: M. Patel (голова),J. Calhoon, G. Dehmer, J. Grantham, T. Maddox, D. Maron, P. Smith
Література
1. Adult Treatment Panel III. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143-3421.
2. Aqel R, Zoghbi GJ, Hage F, et al. Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve. Catheter Cardiovasc Interv. 2008;72:479-485.
3. Arnold SV, Grodzinsky A, Gosch KL, et al. Predictors of physician under-recognition of angina in outpatients with stable coronary artery disease. Circ Cardiovasc Qual Outcomes. 2016;9:554-559.
4. Barbash IM, Dvir D, Torguson R, et al. Prognostic implications of percutaneous coronary interventions performed according to the appropriate use criteria for coronary revascularization. Cardiovasc Revasc Med. 2013;14:316-320.
5. Barner HB, Barnett MG. Fifteen- to twenty-oneyear angiographic assessment of internal thoracic artery as a bypass conduit. Ann Thorac Surg. 1994;57:1526-1528.
6. Bradley SM, Spertus JA, Kennedy KF, et al. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. JAMA Intern Med. 2014;174:1630-1639.
7. Buchanan A. Medical paternalism. Philos Public Aff. 1978;7:370-390.
8. Chan PS, Rao SV, Bhatt DL, et al. Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions. J Am Coll Cardiol. 2013;62:2274-2281.
9. Chewning B, Bylund CL, Shah B, et al. Patient preferences for shared decisions: a systematic review. Patient Educ Couns. 2012;86:9-18.
10. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
11. Coley C, Barry M, Mulley A. Screening for prostate cancer. Ann Intern Med. 1977;126:480-484.
12. De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208-1217.
13. De la Torre Hernandez JM, Hernandez HF, Alfonso F, et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol 2011;58:351-358.
14. Desai NR, Bradley SM, Parzynski CS, et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA. 2015;314:2045-2053.
15. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64:1929-1949.
16. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/ AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44-164.
17. Hannan EL, Zhong Y, Walford G, et al. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. J Am Coll Cardiol. 2014;64:2717-2726.
18. Harold JG, Bass TA, Bashore TM, et al. ACCF/AHA/ SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/ American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). J Am Coll Cardiol. 2013;62:357-396.
19. Hemingway H, Crook AM, Feder G, et al. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med. 2001;344:645-654.
20. Hendel RC, Patel MR, Allen JM, et al. Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2013;61:1305-1317.
21. Hillis LD, Smith P, Anderson J, et al. 2011 ACCF/ AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:e123- 210.
22. Hlatky MA, Boothroyd DB, Baker LC, Go AS. Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention. Am Heart J. 2015;169:149-154.
23. Jacobs AK, Kushner FG, Ettinger SM, et al. ACCF/ AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:213-265.
24. Kern MJ, Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol. 2010;55:173-185.
25. Ko DT, Guo H, Wijeysundera HC, et al. Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease. J Am Coll Cardiol. 2012;60:1876-1884.
26. Laouri M, Kravitz RL, French WJ, et al. Underuse of coronary revascularization procedures: application of a clinical method. J Am Coll Cardiol. 1997;29:891-897.
27. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44-122.
28. Levine GN, O’Gara PT, Bates ER, et al. 2015 ACC/ AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/ AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2016;67:1235-1250.
29. Lin GA, Fagerlin A. Shared decision making: state of the science. Circ Cardiovasc Qual Outcomes. 2014;7:328-334.
30. Marso SP, Teirstein PS, Kereiakes DJ, et al. Percutaneous coronary intervention use in the United States: defining measures of appropriateness. J Am Coll Cardiol Intv. 2012;5:229-235.
31. Mulley AG Jr, Eagle KA. What is inappropriate care? JAMA. 1988;260:540-541.
32. Nam CW, Mangiacapra F, Entjes R, et al. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol. 2011;58:1211-1218.
33. Patel MR, Dehmer GJ, Hirshfeld JW. et al, ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/ SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 2012;59:857-881.
34. Sabik JF. III, Lytle BW, Blackstone EH, et al. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg. 2005;79:544-551.
35. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
36. Shafiq A, Arnold SV, Gosch K, et al. Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study. Am Heart J. 2016;175:94-100.
37. Smith SCJr, Benjamin EJ, Bonow RO, et al. AHA/ ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. J Am Coll Cardiol. 2011;58:2432-2446.
38. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. 2011:CD001431.
39. Ting HH, Brito JP, Montori VM. Shared decision making: science and action. Circ Cardiovasc Qual Outcomes. 2014;7:323-327.
40. Toth G, De BB, Casselman F, et al. Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circulation. 2013;128:1405-1411.
41. Von Eschenbach A, Ho R, Murphy G, et al. American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin. 1997:261-264.
42. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med. 2004;140:54-59.
43. Windecker S, Stortecky S, Stefanini G.G, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network metaanalysis. BMJ. 2014;348:g3859.
[PDF] | [Зміст журналу] |